Development and Validation of the AFSymp™: an Atrial Fibrillation-specific Measure of Patient-reported Symptoms

Overview

Journal Patient

Specialty Health Services

Date 2014 Apr 16

PMID 24733480

Citations 4

Authors

Jennie Medin

Rob Arbuckle

Linda Abetz

Katarina Halling

Karoly Kulich

Nils Edvardsson

Karin S Coyne

Affiliations

Soon will be listed here.

Abstract

Background: Patients with atrial fibrillation (AF) can be severely incapacitated by symptoms, but validated symptom measures are lacking. The aim of this study was to develop an AF-specific symptom questionnaire (AFSymp™).

Methods: Following a literature review, qualitative interviews with 91 patients (United States [US], n = 30; United Kingdom [UK], n = 16; France, n = 15; Germany, n = 15; Japan, n = 15) with paroxysmal, persistent, and permanent AF were conducted to identify emergent concepts and to develop the items and response options for the AFSymp™. Clinical experts (n = 21) in the US, the UK, France, Germany, and Japan provided feedback on the most clinically relevant symptoms via an email survey. Cognitive interviews with 30 patients were conducted to evaluate content validity. A prospective, observational, psychometric evaluation study (n = 313) consisting of two study visits was performed at 32 sites across the US.

Results: After item reduction, the AFSymp™ consisted of 11 items with a 1-week recall period. Exploratory and confirmatory factor analysis resulted in three subscales (heart symptoms, tiredness, chest discomfort) and two items: dizziness and shortness of breath. Internal consistency was strong across subscales (Cronbach's α 0.82-0.91). The test-retest reliability of items and subscales was acceptable (intra-class correlation [ICC] 0.58-0.78). The reproducibility of the single global score was strong (ICC 0.78). The construct and known-groups validity was acceptable.

Conclusion: The AFSymp™ demonstrates evidence of reliability and validity as a comprehensive measure of AF symptoms that can be used to assess patient outcomes in clinical and research settings. More research is needed to evaluate the instrument's responsiveness.

Citing Articles

Can we collect health-related quality of life information from anticoagulated atrial fibrillation participants who have recently experienced a bleed? An observational feasibility study in primary and secondary care in Wales and through a UK online....

Hutchings H, Lanyon K, Holland G, Alikhan R, Jenkins R, Laing H BMJ Open. 2023; 13(10):e075335.

PMID: 37802619 PMC: 10565208. DOI: 10.1136/bmjopen-2023-075335.

Translation and Validation of the Arrhythmia-Specific Questionnaire in Tachycardia and Arrhythmia (ASTA) to the Brazilian Context: An Instrument Focusing on Arrhythmia Symptoms.

Cannavan P, Cannavan F, Walfridsson U, Lopes M Cardiol Res Pract. 2020; 2020:1402916.

PMID: 32351731 PMC: 7171627. DOI: 10.1155/2020/1402916.

Symptoms In Atrial Fibrillation: A Contemporary Review And Future Directions.

Heidt S, Kratz A, Najarian K, Hassett A, Oral H, Gonzalez R J Atr Fibrillation. 2016; 9(1):1422.

PMID: 27909518 PMC: 5089512. DOI: 10.4022/jafib.1422.

Assessing the Impact of Caring for a Person with Schizophrenia: Development of the Schizophrenia Caregiver Questionnaire.

Gater A, Rofail D, Marshall C, Tolley C, Abetz-Webb L, Zarit S Patient. 2015; 8(6):507-20.

PMID: 25680337 PMC: 4662958. DOI: 10.1007/s40271-015-0114-3.

References

McHorney C, Ware Jr J, Lu J, Sherbourne C . The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994; 32(1):40-66. DOI: 10.1097/00005650-199401000-00004. View

Thrall G, Lane D, Carroll D, Lip G . Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006; 119(5):448.e1-19. DOI: 10.1016/j.amjmed.2005.10.057. View

Brooks R . EuroQol: the current state of play. Health Policy. 1996; 37(1):53-72. DOI: 10.1016/0168-8510(96)00822-6. View

Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers G . The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000; 36(4):1303-9. DOI: 10.1016/s0735-1097(00)00886-x. View

Steg P, Alam S, Chiang C, Gamra H, Goethals M, Inoue H . Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart. 2011; 98(3):195-201. DOI: 10.1136/heartjnl-2011-300550. View

Roalfe A, Bryant T, Davies M, Hackett T, Saba S, Fletcher K . A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study. Europace. 2012; 14(10):1420-7. DOI: 10.1093/europace/eus102. View

Juniper E, Guyatt G, Willan A, Griffith L . Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994; 47(1):81-7. DOI: 10.1016/0895-4356(94)90036-1. View

McHorney C, Kosinski M, Ware Jr J . Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey. Med Care. 1994; 32(6):551-67. DOI: 10.1097/00005650-199406000-00002. View

Harden M, Nystrom B, Kulich K, Carlsson J, Bengtson A, Edvardsson N . Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation. Health Qual Life Outcomes. 2009; 7:65. PMC: 2717073. DOI: 10.1186/1477-7525-7-65. View

10.

Guedon-Moreau L, Capucci A, Denjoy I, Morgan C, Perier A, Leplege A . Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. Europace. 2010; 12(5):634-42. PMC: 2859876. DOI: 10.1093/europace/euq007. View

11.

Jaeschke R, Singer J, Guyatt G . A comparison of seven-point and visual analogue scales. Data from a randomized trial. Control Clin Trials. 1990; 11(1):43-51. DOI: 10.1016/0197-2456(90)90031-v. View

12.

Arribas F, Ormaetxe J, Peinado R, Perulero N, Ramirez P, Badia X . Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace. 2010; 12(3):364-70. DOI: 10.1093/europace/eup421. View

13.

Bubien R, Plumb V, Kay G . Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996; 94(7):1585-91. DOI: 10.1161/01.cir.94.7.1585. View

14.

McHorney C, TARLOV A . Individual-patient monitoring in clinical practice: are available health status surveys adequate?. Qual Life Res. 1995; 4(4):293-307. DOI: 10.1007/BF01593882. View

15.

McHorney C, Ware Jr J, Raczek A . The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993; 31(3):247-63. DOI: 10.1097/00005650-199303000-00006. View

16.

Singer D, Albers G, Dalen J, Go A, Halperin J, Manning W . Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl):429S-456S. DOI: 10.1378/chest.126.3_suppl.429S. View

17.

Frost M, Reeve B, Liepa A, Stauffer J, Hays R . What is sufficient evidence for the reliability and validity of patient-reported outcome measures?. Value Health. 2007; 10 Suppl 2:S94-S105. DOI: 10.1111/j.1524-4733.2007.00272.x. View

18.

Ware Jr J, Sherbourne C . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83. View